iShares Biotechnology ETF
821 hedge funds and large institutions have $3.97B invested in iShares Biotechnology ETF in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 193 increasing their positions, 355 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
821
Holders Change
-44
Holders Change %
-5.09%
% of All Funds
11.15%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.11%
New
49
Increased
193
Reduced
355
Closed
78
Calls
$293M
Puts
$630M
Net Calls
-$338M
Net Calls Change
+$66.5M
Top Buyers
| 1 |
1
Citigroup
New York
|
$410M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$181M |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$113M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$61.2M |
| 5 |
5
Squarepoint
New York
|
$9.21M |
Top Sellers
| 1 |
1
Jane Street
New York
|
$32.8M |
| 2 |
2
Morgan Stanley
New York
|
$359M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$891M |
| 4 |
4
BNP Paribas Financial Markets
Paris,
France
|
$117M |
| 5 |
5
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$97.8M |